Roberts Glore & Co is an investment manager that focuses on designing and implementing personalized investment management strategies for its clients. The firm was founded in 1984 through a partnership bringing together individuals with experience in investment management. Roberts Glore & Co submitted its SEC 13F Filings for the third quarter ending September 30, 2014, on November 4, 2014. The filing indicates that the firm’s top three stock holdings are Berkshire Hathaway Inc. (NYSE:BRK.B), Johnson & Johnson (NYSE:JNJ), and Stryker Corporation (NYSE:SYK).
Berkshire Hathaway Inc. (NYSE:BRK.B) came out as the biggest investment of the firm with a total investment value of $8.3 million. Berkshire Hathaway Inc. (NYSE:BRK.B) is the famous Warren Buffett holding company that oversees and manages a number of subsidiaries that function in different markets. The company’s main business is insurance on the national platform and reinsurance on the international platform. The top shareholders of Berkshire Hathaway Inc. (NYSE:BRK.B) are Buffett Warren Edward, Fidelity Management & Research Co., and Gottesman David Sanford.
Johnson & Johnson (NYSE:JNJ) emerged the second largest investment of Roberts Glore & Co, accounting for a total investment value of $6.6 million. Johnson & Johnson (NYSE:JNJ) is a manufacturer of health products and is a provider of pharmaceutical, consumer, and medical devices services. The company reported its third quarter results on October 14, 2014, with total sales of $18.5 billion, representing a 5.1% increase over the same quarter of the previous year. The company is focused on completing the $1.75 billion deal for the acquisition of Alios BioPharma Inc. During the fourth quarter, no acquisitions have been announced by the company although the company came into the quarter with $31.62 billion.
Stryker Corporation (NYSE:SYK) was the third biggest investment of Roberts Glore & Co, representing an investment value of $3.8 million. Stryker Corporation (NYSE:SYK) is a medical devices developer, manufacturer, and marketer. The company manufactures a wide array of medical products including biologics, neurologic, ear surgical navigation, among many others. Stryker Corporation (NYSE:SYK) has received the Prix Galien USA 2014 Award for Best Medical Technology for its Trevo ProVue Retriever, which is a clot removal device that’s fully visible during the medical procedure for precise positioning within the clot.
This article has been written by Victor Ochieng.
